Table 1.
Clinical characteristics of all subjects with and without TNs.
| Variables | TNs (n = 986) | Non-TNs (n = 1082) | P | SMD |
|---|---|---|---|---|
| Age (years) | 47.23 (13.99) | 36.93 (11.32) | <0.001∗∗ | 0.809 |
| Gender (female, n) | 467 (47.4) | 254 (23.5) | <0.001∗∗ | 0.516 |
| Creatinine (mmol/L) | 75.10 (22.58) | 77.08 (17.38) | <0.001∗∗ | 0.098 |
| Body mass index (kg/m2) | 24.04 (6.55) | 23.52 (2.84) | 0.002∗ | 0.104 |
| Systolic blood pressure (mmHg) | 122.87 (13.86) | 118.53 (12.16) | <0.001∗∗ | 0.333 |
| Diastolic blood pressure (mmHg) | 79.45 (9.57) | 77.75 (9.94) | <0.001∗∗ | 0.174 |
| Fasting blood sugar (mmol/L) | 5.56 (1.09) | 5.26 (1.02) | <0.001∗∗ | 0.277 |
| Uric acid (mmol/L) | 392.35 (98.97) | 401.44 (97.05) | 0.035∗ | 0.093 |
| Triglyceride (mmol/L) | 1.38 (0.84) | 1.34 (1.05) | <0.001∗∗ | 0.036 |
| Cholesterol (mmol/L) | 5.03 (0.89) | 4.78 (0.88) | <0.001∗∗ | 0.281 |
| High-density lipoprotein (mmol/L) | 1.42 (0.33) | 1.39 (0.33) | 0.113 | 0.070 |
| Low-density lipoprotein (mmol/L) | 2.99 (0.76) | 2.79 (0.74) | <0.001∗∗ | 0.263 |
| Thyroid stimulating hormone (mIU/L) | 1.79 (0.96) | 1.90 (0.90) | 0.005∗ | 0.124 |
| Free triiodothyronine (nmol/L) | 5.15 (0.58) | 5.20 (0.53) | 0.031∗ | 0.095 |
| Free thyroxine (nmol/L) | 15.76 (2.18) | 16.23 (2.20) | <0.001∗∗ | 0.215 |
| White blood cell (109 cells/L) | 6.55 (1.72) | 6.34 (1.56) | 0.003∗ | 0.131 |
| Neutrophil (109 cells/L) | 3.64 (1.25) | 3.54 (1.19) | 0.064 | 0.081 |
| Lymphocyte (109 cells/L) | 2.32 (0.67) | 2.23 (0.58) | 0.001∗ | 0.148 |
| Monocyte (109 cells/L) | 0.40 (0.13) | 0.39 (0.12) | 0.041∗ | 0.090 |
| Neutrophil/lymphocyte ratio | 1.66 (0.73) | 1.67 (0.64) | 0.767 | 0.005 |
| Lymphocyte/monocyte ratio | 6.22 (2.27) | 6.10 (1.92) | 0.514 | 0.057 |
| Monocyte/high-density lipoprotein ratio | 0.30 (0.14) | 0.30 (0.13) | 0.516 | 0.029 |
Data were presented as mean (SD) or number (%). TNs: thyroid nodules; SMD: standardized mean difference. ∗P < 0.05; ∗∗P < 0.001.